KALEIGH VINESKY: Open Payments
NPI 1598118655 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 18 payments from 11 companies in 2025. Trend: 2023 $377 · 2024 $625 · 2025 $459
Food & beverage: $360Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $146 |
| Sage Therapeutics, LLC | 4 | $120 |
| Amgen Inc. | 3 | $55 |
| Smith+Nephew, Inc. | 1 | $20 |
| SANOFI PASTEUR INC. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $17 |
| Dexcom, Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $17 |
| SHIELD THERAPEUTICS INC | 1 | $14 |
Products named: ZURZUVAE, EVENITY, Veozah, STRAVIX PL, BEYFORTUS, MYFEMBREE, LO LOESTRIN FE, Dexcom G6 Transmitter.
Industry payments across PA — which companies pay providers there.
